FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RALTEGRAVIR
异名/同义词4-PYRIMIDINECARBOXAMIDE, N-((4-FLUOROPHENYL)METHYL)-1,6-DIHYDRO-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-
L000900612
L-000900612
MK-0518
N-(2-(4-(4-FLUOROBENZYLCARBAMOYL)-5-HYDROXY-1-METHYL-6-OXO-1,6- DIHYDROPYRIMIDIN-2-YL)PROPAN-2-YL)-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE
RALTEGRAVIR
RALTEGRAVIR [EMA EPAR]
RALTEGRAVIR [INN]
RALTEGRAVIR [MART.]
RALTEGRAVIR [MI]
RALTEGRAVIR [VANDF]
RALTEGRAVIR [WHO-DD]
CAS登记号518048-05-0
物质唯一标识(Unique Ingredient Identifier)22VKV8053U
分子式C20H21FN6O5
国际化合物标识(International Chemical Identifier,InChI)CZFFBEXEKNGXKS-UHFFFAOYSA-N
SMILESN(C(c1nc(c(c(n1C)=O)O)C(NCc2ccc(cc2)F)=O)(C)C)C(c3oc(nn3)C)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System